
Mosaic trisomy 22 in a 4‐year‐old boy with congenital heart disease and general hypotrophy: A case report
Author(s) -
Kalayinia Samira,
Shahani Tina,
Biglari Alireza,
Maleki Majid,
RokniZadeh Hassan,
Razavi Zahra,
Mahdieh Nejat
Publication year - 2019
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.22663
Subject(s) - trisomy , genetic counseling , medicine , karyotype , aneuploidy , pediatrics , germline mosaicism , genetics , phenotype , chromosome , biology , gene
Background Trisomy 22 mosaicism is a rare autosomal anomaly with survival compatibility. Recognition of the complete trisomy 22 which is incompatible with life from the mosaic form is critical for genetic counseling. Affected mosaic cases have prevalent clinical presentations such as webbed neck, developmental delay, abnormal ears, cardiac disorders, and microcephaly. Phenotype of these patients is milder than full chromosomal aneuploidy, and the severity of the phenotype depends on the count of trisomic cells. We describe a 4‐year‐old boy with mosaic trisomy 22 from healthy parents and no family history of any genetic disorders in the pedigree. Method and Results The patient had determined dysmorphic clinical features including facial asymmetry, cleft palate, gastroenteritis, hydronephrosis, developmental delay, genital anomalies, dysplastic toenails, flattened nasal bridge, congenital heart defect, hearing loss, cryptorchidism, and hypotonic muscle. He is the first reported with hypothyroidism and larynx wall thickness in worldwide and the first with atrial septal defect ( ASD ) from Iran. Chromosomal analyses using G‐banding indicated a de novo Mos 47, XY ,+22(6)/46, XY (44) karyotype with no other chromosomal structural changes. Conclusions Our observations confirm the importance of cytogenetic analyses for determining the cause of congenital anomalies and provide a useful genetic counseling. In addition, due to the fact that some of mosaic trisomy 22 features are unavoidable such as CHD and general hypotrophy, we suggest including echocardiography test for early diagnosis during the clinical assessment.